Charcot-Marie-Tooth Disease Clinical Trial
Official title:
Development of the Charcot-Marie-Tooth Disease Infant Scale (CMTInfS) for Infants With CMT
The purpose of this study is to develop and validate a clinical outcome measure to evaluate disability and disease progression of children 3 years of age and younger (infants and toddlers) with various types of Charcot-Marie-Tooth disease (CMT).
Most forms of CMT begin in childhood and progress throughout a person's lifetime. Current research suggests that treatment to slow disease progression may be most effective if introduced early in a patient's life before muscle weakness and sensation loss develop, as it may be easier to slow disease progression than to reverse disability that is already in place. Clinical outcome measures have been developed for adults (CMT Neuropathy Score) and for children 3 years of age and older (CMT Pediatric Scale). However, no CMT-specific clinical outcome measure currently exists to measure disease severity or progression in children from birth to 3 years of age. It is the goal of this study to develop and validate the CMT Infant Scale (CMTInfS) to meet this need. ;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06203093 -
Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking
|
||
Recruiting |
NCT03782883 -
The Impact of Charcot-Marie-Tooth Disease in the Real World
|
||
Terminated |
NCT03254199 -
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
|
Phase 2 | |
Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
Completed |
NCT00149045 -
Follow up and Observation of Charcot Marie Tooth Disease in Families
|
N/A | |
Completed |
NCT04786522 -
Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease
|
||
Recruiting |
NCT05011006 -
NT-3 Levels and Function in Individuals With CMT
|
||
Recruiting |
NCT05902351 -
Natural History Study for Charcot Marie Tooth Disease
|
||
Terminated |
NCT03943290 -
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
|
Phase 2 | |
Active, not recruiting |
NCT04762758 -
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
|
Phase 3 | |
Completed |
NCT02788734 -
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
|
N/A | |
Recruiting |
NCT02532244 -
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
|
||
Terminated |
NCT05827419 -
Hearing and Balance Disorders in Peripheral Neuropathy
|
||
Terminated |
NCT03124459 -
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
|
Phase 2 | |
Terminated |
NCT03810508 -
A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)
|
||
Recruiting |
NCT04010188 -
A Registered Cohort Study on Charcot-Marie-Tooth Disease
|
||
Completed |
NCT00271635 -
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
|
Phase 2 | |
Completed |
NCT03715283 -
Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care
|
N/A | |
Completed |
NCT02001038 -
Survey of Current Management of Orthopaedic Complications in CMT Patients
|
N/A | |
Not yet recruiting |
NCT01289704 -
Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
|
Phase 2/Phase 3 |